Roche aims to be an effective and valued healthcare partner. This is how we see ourselves and how we strive to be viewed by NHS managers and healthcare professionals, government bodies and patient groups alike.
As one of the major pharmaceutical and diagnostic companies in the UK, Roche develops and provides an innovative range of products and services that help healthcare professionals improve the health and well-being of the UK population.
Supporting our medicines are a range of innovative services that add value for patients, clinicians, health service commissioners and NHS managers. We support the aims of government in enabling more services to be delivered in the community setting, such as GP surgeries; improved patient choice; and supporting early disease intervention to prevent long term suffering. In particular, many of our innovative oral treatments themselves enable the shift from hospital to community based care in some cases by replacing intravenous drug treatments, where there is equivalent efficacy, whilst at the same time alleviating capacity pressures in hospitals and freeing up the time of nurses and pharmacists.
For complete information about how we work, you can download our PDF leaflet "Roche a Healthcare Partner with the NHS"
Patient organisations to which Roche provided financial support & types of support received in 2010:
Core funding for the human and physical resources needed to run the organisation and/or activity that the patient group decides to carry out, with no Roche involvement
Funding of specific project, educational or collaborative, to which both parties will contribute
Funding a third party agency to provide support for the patient group in its educational activities
Arthritis and Muscoskeletal Alliance
Core funding, Funding of specific project, Funding a third party agency
Beating Bowel Cancer
Core funding, Funding of specific project, Funding a third party agency
Bowel Cancer UK
Core funding, Funding a third party agency
Breakthrough Breast Cancer
Core funding, Funding of specific project, Funding a third party agency
Cancer Campaigning Group
Core funding
CLL Support Association
Core funding
Hepatitis C Trust
Core funding, Funding of specific project, Funding a third party agency
International Oestoporosis Society
Funding of specific project
Kidney Research UK
Core funding
Leukaemia Care
Funding of specific project
Lymphoma Association
Funding of specific project
National Kidney Federation
Core funding
National Rheumatoid Arthritis Society
Core funding, Funding of specific project
Osteoporosis Dorset
Funding of specific project
Rarer Cancers Forum
Core funding
Roy Castle Lung Cancer Foundation
Funding of specific project
Tenovus
Funding a third party agency
UK Lung Cancer Coalition
Core funding
Kidney Research UK
Funding of specific project
Contact Information:
For more information email welwyn.corporate_affairs@roche.com

